Asthma management, focused on the use of oral corticosteroids: the opinions of Italian asthmatic patients

References

• Global Initiative for Asthma. 2022 GINA Report, Global Strategy for Asthma Management and Prevention. 2022. [accessed 2023 Feb 24]. www.ginasthma.org.
   Google Scholar
• Bleecker ER, Menzies-Gow AN, Price DB, Bourdin A, Sweet S, Martin AL, Alacqua M, Tran TN. Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management. Am J Respir Crit Care Med. 2020;201(3):276–293. doi:10.1164/rccm.201904-0903SO.
   Google Scholar
• Pavord ID. Oral corticosteroid-dependent asthma: current knowledge and future needs. Curr Opin Pulm Med. 2019;25(1):51–58. doi:10.1097/MCP.0000000000000541.
   Google Scholar
• Clark HL, Dixon LJ, Ramachandran S, Leukel PJ, Lee AA. Psychometric Properties of the Short Scale Anxiety Sensitivity Index Among Adults with Chronic Respiratory Disease. J Clin Psychol Med Settings. 2024 Mar;31(1):186-196. doi:10.1007/s10880-023-09976-y.
   Google Scholar
• Tomaszewski EL, Atkinson MJ, Janson C, Karlsson N, Make B, Price D, Reddel HK, Vogelmeier CF, Müllerová H, Jones PW; NOVELTY Scientific Community; NOVELTY study investigators. Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD. Respir Res. 2023 Apr 8;24(1):106. doi:10.1186/s12931-023-02394-6.
   Google Scholar
• Shen Q, von Maltzahn R, Nelsen L, Revicki D. Psychometric Properties of the Asthma Symptom Index in Patients with Severe Asthma. J Allergy Clin Immunol Pract. 2021 Jan;9(1):400-409.e1. doi:10.1016/j.jaip.2020.08.019.
   Google Scholar
• Wilson SR, Mulligan MJ, Ayala E, Chausow A, Huang Q, Knowles SB, Gummidipundi S, Castro M, Wise RA. A new measure to assess asthma's effect on quality of life from the patient's perspective. J Allergy Clin Immunol. 2018 Mar;141(3):1085-1095. doi:10.1016/j.jaci.2017.02.047.
   Google Scholar
• Sweeney J, Patterson CC, Menzies-Gow A, Niven RM, Mansur AH, Bucknall C, Chaudhuri R, Price D, Brightling CE, Heaney LG, et al. Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry. Thorax. 2016;71(4):339–346. doi:10.1136/thoraxjnl-2015-207630.
   Google Scholar
• Lefebvre P, Duh MS, Lafeuille MH, Gonzalo L, Desai U, Robitaille MN, Albers F, Yancey S, Ortega H, Forshag M, et al. Burden of systemic glucocorticoid-related complications in severe asthma. Curr Med Res Opin. 2017;33(1):57–65. doi:10.1080/03007995.2016.1233101.
   Google Scholar
• Canonica GW, Colombo GL, Bruno GM, Di Matteo S, Martinotti C, Blasi F, Bucca C, Crimi N, Paggiaro P, Pelaia G, et al. Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry. World Allergy Organ J. 2019;12(1):100007. doi:10.1016/j.waojou.2018.12.001.
   Google Scholar
• Braido F, Baiardini I, Stagi E, Scichilone N, Rossi O, Lombardi C, Ridolo E, Gani F, Balestracci S, Girbino G, et al. RhinAsthma patient perspective: a short daily asthma and rhinitis QoL assessment. Allergy. 2012;67(11):1443–1450. doi:10.1111/all.12014.
   Google Scholar
• Molinengo G, Baiardini I, Braido F, Loera B. RhinAsthma patient perspective: A Rasch validation study. J Asthma. 2018 Feb;55(2):119-123.
   Google Scholar
• Baiardini I, Fasola S, La Grutta S, Trucco E, Canonica GW, Braido F. Rhinitis and Asthma Patient Perspective (RAPP): Clinical Utility and Predictive Value. J Allergy Clin Immunol Pract. 2022 Mar;10(3):846-852.
   Google Scholar
• Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, Bullinger M, Kaasa S, Leplege A, Prieto L, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International quality of life assessment. J Clin Epidemiol. 1998;51(11):1171–1178. doi:10.1016/s0895-4356(98)00109-7.
   Google Scholar
• Aaron SD, Vandemheen KL, FitzGerald JM, Ainslie M, Gupta S, Lemière C, Field SK, McIvor RA, Hernandez P, Mayers I, et al. Reevaluation of Diagnosis in Adults with Physician-Diagnosed Asthma. JAMA. 2017; 317(3):269–279. doi:10.1001/jama.2016.19627.
   Google Scholar
• Bai TR, Vonk JM, Postma DS, Boezen HM. Severe exacerbations predict excess lung function decline in asthma. Eur Respir J. 2007;30(3):452–456. doi:10.1183/09031936.00165106.
   Google Scholar
• Baldacci S, Simoni M, Maio S, Angino A, Martini F, Sarno G, Cerrai S, Silvi P, Pala AP, Bresciani M, et al. Prescriptive adherence to GINA guidelines and asthma control: An Italian cross sectional study in general practice. Respir Med. 2019;146:10–17. doi:10.1016/j.rmed.2018.11.001.
   Google Scholar
• Braido F, Brusselle G, Guastalla D, Ingrassia E, Nicolini G, Price D, Roche N, Soriano JB, Worth H, and the LIAISON Study Group. Determinants and impact of suboptimal asthma control in Europe: The International cross-sectional and longitudinal assessment on asthma control (LIAISON) study. Respir Res. 2016;17(1):51. doi:10.1186/s12931-016-0374-z.
   Google Scholar
• Axelsson M, Lötvall J. Recent educational interventions for improvement of asthma medication adherence. Asia Pac Allergy. 2012;2(1):67–75. doi:10.5415/apallergy.2012.2.1.67.
   Google Scholar
• van der Meer AN, de Jong K, Ferns M, Widrich C, Ten Brinke A. Overuse of Oral Corticosteroids in Asthma Is Often Underdiagnosed and Inadequately Addressed. J Allergy Clin Immunol Pract. 2022;10(8): 2093–2098. doi:10.1016/j.jaip.2022.03.024.
   Google Scholar
• Taube C, Bramlage P, Hofer A, Anderson D. Prevalence of oral corticosteroid use in the German severe asthma population. ERJ Open Res. 2019;5(4):00092-2019. doi:10.1183/23120541.00092-2019.
   Google Scholar
• Tran TN, MacLachlan S, Hicks W, Liu J, Chung Y, Zangrilli J, Rubino A, Ganz ML. Oral Corticosteroid Treatment Patterns of Patients in the United States with Persistent Asthma. J Allergy Clin Immunol Pract. 2021;9(1):338–346. doi:10.1016/j.jaip.2020.06.019.
   Google Scholar
• Puggioni F, Brussino L, Canonica GW, Blasi F, Paggiaro P, Caminati M, Latorre M, Heffler E, Senna G, Severe Asthma Network in Italy (SANI) group. Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry. J Asthma Allergy. 2020;13:599–604. doi:10.2147/JAA.S274245.
   Google Scholar
• Porsbjerg C, Menzies-Gow A. Co-morbidities in severe asthma: Clinical impact and management. Respirology. 2017;22(4):651–661. doi:10.1111/resp.13026.
   Google Scholar
• Rogliani P, Sforza M, Calzetta L. The impact of comorbidities on severe asthma. Curr Opin Pulm Med. 2020;26(1):47–55. doi:10.1097/MCP.0000000000000640.
   Google Scholar
• Al Efraij K, Johnson KM, Wiebe D, Sadatsafavi M, FitzGerald JM. A systematic review of the adverse events and economic impact associated with oral corticosteroids in asthma. J Asthma. 2019;56(12):1334–1346. doi:10.1080/02770903.2018.1539100.
   Google Scholar
• Skov IR, Madsen H, Henriksen DP, Andersen JH, Pottegård A, Davidsen JR. Low-dose oral corticosteroids in asthma associates with increased morbidity and mortality. Eur Respir J. 2022;60(3):2103054. doi:10.1183/13993003.03054-2021.
   Google Scholar
• Magnoni MS, Latorre M, Bettoncelli G, Sanchez-Herrero MG, Lopez A, Calvo E, Rizzi A, Caminati M, Senna G, Paggiaro P. Asthma control in primary care: the results of an observational cross-sectional study in Italy and Spain. World Allergy Organ J. 2017;10(1):13. doi:10.1186/s40413-017-0144-5.
   Google Scholar
• Lanario JW, Hyland ME, Wei Y, Jones RC, Masoli M. Comparison of the effects of pulmonary and extra-pulmonary symptoms on health-related quality of life in patients with severe asthma. Respir Med. 2020;162:105870. doi:10.1016/j.rmed.2020.105870.
   Google Scholar
• Snyder CF, Aaronson NK, Choucair AK, Elliott TE, Greenhalgh J, Halyard MY, Hess R, Miller DM, Reeve BB, Santana M. Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. Qual Life Res. 2012;21(8):1305–1314. doi:10.1007/s11136-011-0054-x.
   Google Scholar
• Canonica GW, Blasi F, Paggiaro P, Senna G, Passalacqua G, Spanevello A, Aliberti S, Bagnasco D, Bonavia M, Bonini M, et al. Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI). World Allergy Organ J. 2020;13(10):100464. doi:10.1016/j.waojou.2020.100464.
   Google Scholar